These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9105118)

  • 1. The perils of nontreatment of hyperuricemia.
    Hoffman GS
    Cleve Clin J Med; 1997 Apr; 64(4):215. PubMed ID: 9105118
    [No Abstract]   [Full Text] [Related]  

  • 2. A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout.
    Kamatani N; Hosoya T
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S11-2. PubMed ID: 21654264
    [No Abstract]   [Full Text] [Related]  

  • 3. Febuxostat : a viewpoint by Naomi Schlesinger.
    Schlesinger N
    Drugs; 2008; 68(13):1875-6. PubMed ID: 18729539
    [No Abstract]   [Full Text] [Related]  

  • 4. Febuxostat: a viewpoint by H. Ralph Schumacher Jr and Lan X. Chen.
    Schumacher HR; Chen LX
    Drugs; 2008; 68(13):1875-6. PubMed ID: 18729538
    [No Abstract]   [Full Text] [Related]  

  • 5. New therapeutic approach to hyperuricemia and gout in the light of recommendations.
    Lioté F
    Joint Bone Spine; 2016 Jul; 83(4):376-80. PubMed ID: 27085801
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperuricemia: a laboratory finding needing treatment?].
    Keller C
    Verh Dtsch Ges Inn Med; 1990; 96():188-92. PubMed ID: 2092438
    [No Abstract]   [Full Text] [Related]  

  • 7. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
    [No Abstract]   [Full Text] [Related]  

  • 8. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 9. Febuxostat--treatment for hyperuricemia and gout?
    Moreland LW
    N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How PCP education can impact gout management: the gout essentials.
    Weaver AL; Cheh MA; Kennison RH
    J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S42-6. PubMed ID: 18830090
    [No Abstract]   [Full Text] [Related]  

  • 12. Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
    Katayama A; Yokokawa H; Fukuda H; Ono Y; Isonuma H; Hisaoka T; Naito T
    Intern Med; 2019 May; 58(9):1225-1231. PubMed ID: 30626825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic hyperuricemia: to treat or not to treat.
    Dincer HE; Dincer AP; Levinson DJ
    Cleve Clin J Med; 2002 Aug; 69(8):594, 597, 600-2 passim. PubMed ID: 12184468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical revision of the medical treatment of gout in Brazil.
    Azevedo VF; Lopes MP; Catholino NM; Paiva EDS; Araújo VA; Pinheiro GDRC
    Rev Bras Reumatol Engl Ed; 2017; 57(4):346-355. PubMed ID: 28743362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperuricemia and gout. Case report].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):207-9. PubMed ID: 11821992
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of gout.
    Cohen MG
    Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract]   [Full Text] [Related]  

  • 17. Review: Gout: A Roadmap to Approaches for Improving Global Outcomes.
    Dalbeth N; Choi HK; Terkeltaub R
    Arthritis Rheumatol; 2017 Jan; 69(1):22-34. PubMed ID: 27389665
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels.
    Beutler AM; Rull M; Schlesinger N; Baker DG; Hoffman BI; Schumacher HR
    Clin Exp Rheumatol; 2001; 19(5):595. PubMed ID: 11579724
    [No Abstract]   [Full Text] [Related]  

  • 19. Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S19-26. PubMed ID: 21654266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of gout: where are we now?
    Richette P
    Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i1-i3. PubMed ID: 29272509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.